Patents
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
03/2004
03/31/2004CN1486177A Method and preparation for binding acetaldehyde in saliva, stomach and large intestine
03/31/2004CN1486176A Pharmaceutical compositions comprising amlodipine maleate
03/31/2004CN1486175A Powdery preparations and proecss for producing the same
03/31/2004CN1485362A Ion cross-linked chitosan microballoon, its preparing process and use
03/31/2004CN1485343A Production method of specific IgY for venereal disease and its combined preparation
03/31/2004CN1485094A Natural porous polymer beads, the preparation and application thereof
03/31/2004CN1485088A Cinese material medical preparation for curing children' hyperkinetic symptom and the preparation process thereof
03/31/2004CN1485086A Peroral Chinese medicine powder for treating bone fracture and its preparing process
03/31/2004CN1485085A Appetizing promoting digestion oral liquid and the preparation thereof
03/31/2004CN1485084A A reducing fever anti-cold medicine combination and the preparation process thereof
03/31/2004CN1485083A Capsule for thyroid cancer / tumor and lymph node
03/31/2004CN1485082A Blumea oil soft capsule
03/31/2004CN1485081A Buccal tablets for curing acute or chronic pharyngitis and buccal inflammation and the preparation technology thereof
03/31/2004CN1485080A Navel compressing expectorate-easing ointment and the producing method thereof
03/31/2004CN1485075A Lotion for treating hyperosteogeny
03/31/2004CN1485072A Coix seed oil soft capsule for curing prostate diseases and the application thereof
03/31/2004CN1485068A Paster of external use for lumbocrural pain
03/31/2004CN1485061A Gingko leaf drop pill
03/31/2004CN1485045A Medication composition dispelling wind, facilitating ATP synthesis, building up immune competency
03/31/2004CN1485043A Adetphos sodium chloride injection and its preparation method
03/31/2004CN1485041A Hemin chewing tablet and its preparation method
03/31/2004CN1485038A Fibrauretine powder and injection preparation
03/31/2004CN1485036A Compound demerol formulation
03/31/2004CN1485034A Rifaximin suspension mix granule formulation
03/31/2004CN1485033A Rifaximin capsule
03/31/2004CN1485031A Medication oral liquid
03/31/2004CN1485028A Lycopene drop pill
03/31/2004CN1485027A Liposome anti-fungus medication sprayer formulation
03/31/2004CN1485026A Intravenous injection liquid preparing method of oxygen-enriched broad transfusion
03/31/2004CN1484972A Anti-diarrhea yelk antibody feed additive for swine and injection formulation, and preparation method
03/31/2004CN1484966A Compound tea encapsulating moulding method
03/31/2004CN1143859C Camptothecin derivative and its preparation
03/31/2004CN1143689C Aqueous coated composition and method for preparing solid medicine formulation
03/31/2004CN1143688C Triacetin as transdermal permeation enhancer
03/31/2004CN1143683C Exterior-applied black plaster for treating bone diseases and its preparing process
03/31/2004CN1143679C Method and material for treating and preventing mucosal tissue inflammation
03/31/2004CN1143678C Use of VC-magnesium phosphate ester in preparation of medication for constipation
03/31/2004CN1143673C Improvement in the taste of active pharmaceutical ingredients
03/31/2004CN1143672C Pharmaceutical compositions comprising uridine triphosphate
03/30/2004US6713772 Free-form fabrication using multi-photon excitation
03/30/2004US6713616 Detecting binding
03/30/2004US6713533 Nanocapsules and method of production thereof
03/30/2004US6713509 High molecular weight crosslinked acrylic acid polymer, dibasic calcium phosphate and phosphodiesterase isozyme denominated 4 inhibitor; chronic obstructive pulmonary disease (copd)
03/30/2004US6713495 Magnesium omeprazole
03/30/2004US6713470 Method of treatment
03/30/2004US6713461 Eletriptan and sulphobutylether-beta-cyclodextrin; well tolerated intranasal delivery; bioavailability; fast acting
03/30/2004US6713454 Prodrugs of etoposide and etoposide analogs
03/30/2004US6713446 Boronic acid compounds obtained by lyophilization of an aqueous mixture of the boronic acid compound and a sugar having at least two hydroxyl groups; shelf life
03/30/2004US6713293 Encapsulated cells containing an amplified expression vector as a drug delivery device
03/30/2004US6713176 Processing and manufacturing methods enabled using non-stoichiometric nanomaterials
03/30/2004US6713097 Use of a preparation of cimicifuga racemosa
03/30/2004US6713090 Apparatus and method for preparing microparticles
03/30/2004US6713089 Under acidic conditions; nonsteroid antiinflammatory nsaid; crushing strength
03/30/2004US6713087 Method of producing submicron particles of a labile agent and use thereof
03/30/2004US6713086 Side effect reduction, treatment of migraine, epilepsy, mania associated with a bipolar disorders, once a day dosage, an oral osmotic pump formulations, containing hydroxypropyl-methyl cellulose
03/30/2004US6713083 Porous core of a first bioabsorbable material and a substantially non-porous layer of a second bioabsorbable material around the core.
03/30/2004US6713081 Ocular therapeutic agent delivery devices and methods for making and using such devices
03/30/2004US6713079 Contacting the site of wound with a matrix comprising gelatin and a nitric oxide scavanger to increase blood cirulation; nitric oxide scavanger are selected from l-arganine analog, dextran, heparin, cysteine and cystine
03/30/2004US6713073 Whole body spray
03/30/2004US6713048 Δ9 tetrahydrocannabinol (Δ9 THC) solution metered dose inhalers and methods of use
03/30/2004US6713047 Mixture of hfa 134a and hfa 227 allows modulation of the mass median aerodynamic diameter (mmad) of the aerosol particles to target specific regions of the repiratory tract
03/30/2004US6712803 Drug dispensing system
03/30/2004US6712782 Brachytherapy apparatus and methods
03/30/2004US6712610 Characterization of an antibiotic impregnated delivery system as an intracanal medicament in endodontic therapy and method
03/30/2004US6712121 Antimicrobially-treated fabrics
03/30/2004CA2304110C Theophylline sustained release tablet
03/30/2004CA2296231C Composition and method for treating common viral infections
03/30/2004CA2201611C Saponin preparations and use thereof in iscoms
03/30/2004CA2178602C Microcapsules, method of making and their use
03/30/2004CA2162993C Solid fat nanoemulsions as drug delivery vehicles
03/30/2004CA2152907C Antiviral topical pharmaceutical compositions
03/30/2004CA2148043C Solid pharmaceutical dosage form containing flavored film coating
03/30/2004CA2136233C Health supplements containing phyto-oestrogens, analogues or metabolites thereof
03/30/2004CA2136103C Antibiotic cryptdin peptides and methods of their use
03/30/2004CA2127805C Composition for nasal administration
03/30/2004CA2109065C Bioartificial endocrine device
03/30/2004CA2103518C Production of microcapsules of water-soluble drugs
03/30/2004CA2067924C N-alkylenepiperidino compounds and their enantiomers, process for preparing them and pharmaceutical compositions containing them
03/25/2004WO2004025416A2 Bioinformatic method for identifying surface-anchored proteins from gram-positive bacteria and proteins obtained thereby
03/25/2004WO2004024919A1 Non-sequence complementary antiviral oligonucleotides
03/25/2004WO2004024868A2 Product and process for liquefaction of mucus or sputum
03/25/2004WO2004024777A1 Hydroxyalkyl starch derivatives
03/25/2004WO2004024776A1 Method of producing hydroxyalkyl starch derivatives
03/25/2004WO2004024761A1 Hasylated polypeptides, especially hasylated erythropoietin
03/25/2004WO2004024754A1 Proline ester and preparation containing the same for percutaneous administration
03/25/2004WO2004024695A1 Novel molecules derived from noraporphine
03/25/2004WO2004024669A1 Treatment of cns disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine and its formamide
03/25/2004WO2004024343A1 Precipitation of solid particles from droplets formed using focused acoustic energy
03/25/2004WO2004024339A1 Method and apparatus for applying powder in a pattern to a substrate
03/25/2004WO2004024226A1 Device for delivering a viscous medical solution to the nasal membrane and method for using same
03/25/2004WO2004024225A1 System and method for delivering a composition to the nasal membrane
03/25/2004WO2004024213A2 Aerosolized capreomycin for inhibition of pulmonary tuberculosis
03/25/2004WO2004024211A2 Method and device for painless injection of medication
03/25/2004WO2004024209A2 Materials and methods for drug delivery and uptake
03/25/2004WO2004024187A2 Compositions to reduce congestion and methods for application thereof to the nasal membrane
03/25/2004WO2004024184A1 Sustained release preparation
03/25/2004WO2004024175A1 Cancer antigen peptide preparation
03/25/2004WO2004024168A1 Composition and method for use in intestinal cleansing procedures
03/25/2004WO2004024164A1 Stable eye drops containing latanoprost as the active ingredient
03/25/2004WO2004024155A1 Adhesive patch